Drugs / 13C,15N-Urea
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05599048 | Dec 2022 → Jan 2027 expected | neoplasm | Robert Bok, MD, PhD | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 13C,15N-Urea | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05599048 ↗ |
| Route | Intravenous | “Given IV” NCT05599048 ↗ |